Bond.az - BMO Capital raised its price target on Israel Chemicals Ltd (NYSE:ICL) to $6.50 from $6.00 while maintaining a Market Perform rating. The stock trades at a Price/Book ratio of 1.39.
The firm updated its model after Q1 results. BMO now projects 2026 EBITDA roughly $100 million higher than prior estimates.
The revised forecast sits in the upper half of Israel Chemicals' raised EBITDA guidance of $1.5-$1.7 billion. The company reported trailing twelve-month EBITDA of $1.28 billion as of Q1 2026.
The increase is driven mainly by improved potash prices and margins, with smaller contributions from bromine and industrial products.
The $6.50 target represents about 6 times BMO's 2026 EV/EBITDA estimate for ICL.
